Plunkett Research Online: Protalex Inc

PROTALEX INC (PRTX:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Protalex Inc is engaged in the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and immune thrombocytopenia......



Protalex Inc
Ticker: PRTX
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 215 862-9720
Fax:
Address: 131 Columbia Turnpike
Suite 1
Florham Park, NJ 07932 United States

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Arnold KlingCEO/Director/President
Kirk WarshawCFO/Chief Accounting Officer/Director/Secretary
See More
Protalex Inc is engaged in the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and immune thrombocytopenia......See More See More

Auditor: Liggett & Webb, P.A
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: